Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
xmlinkhub
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
Personalized Management of Advanced Kidney Cancer | American Society of Clinical Oncology Educational Book
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
Thumbnails — IMDC | International mRCC Database Consortium
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
Overall survival in metastatic renal cell carcinoma patients after... | Download Scientific Diagram
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
